345 related articles for article (PubMed ID: 27002937)
1. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
[TBL] [Abstract][Full Text] [Related]
3. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
5. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.
Zhu W; Guo L; Zhang B; Lou L; Lin Z; Zhu X; Ren N; Dong Q; Ye Q; Qin L
Ann Surg Oncol; 2014 Apr; 21(4):1304-13. PubMed ID: 24366422
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.
Gao Q; Wang XY; Qiu SJ; Yamato I; Sho M; Nakajima Y; Zhou J; Li BZ; Shi YH; Xiao YS; Xu Y; Fan J
Clin Cancer Res; 2009 Feb; 15(3):971-9. PubMed ID: 19188168
[TBL] [Abstract][Full Text] [Related]
8. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
9. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
[TBL] [Abstract][Full Text] [Related]
12. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.
Feng LH; Dong H; Lau WY; Yu H; Zhu YY; Zhao Y; Lin YX; Chen J; Wu MC; Cong WM
J Cancer Res Clin Oncol; 2017 Feb; 143(2):293-303. PubMed ID: 27743138
[TBL] [Abstract][Full Text] [Related]
13. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.
Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
[TBL] [Abstract][Full Text] [Related]
15. Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.
Notake T; Kobayashi A; Shinkawa H; Kawahara T; Shimizu A; Yokoyama T; Hasegawa K; Kokudo N; Matsuyama Y; Makuuchi M; Miyagawa SI
Int J Clin Oncol; 2017 Aug; 22(4):715-725. PubMed ID: 28303401
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.
Cai MY; Wang FW; Li CP; Yan LX; Chen JW; Luo RZ; Yun JP; Zeng YX; Xie D
Chin J Cancer; 2016 Aug; 35(1):80. PubMed ID: 27527497
[TBL] [Abstract][Full Text] [Related]
17. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
18. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
[TBL] [Abstract][Full Text] [Related]
19. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]